leisure time -WSS

leisure time

author：focus 2025-09-30 09:29:27 - browse：461

The removal of small amounts of brain tissue from desperately ill patients, done as part of a Mount Sinai research project, triggered alarm bells at the Food and Drug Administration and has raised broader questions about the scientific and ethical justification for live-brain research. Journalist and STAT contributor Katherine Eban joins “The Readout LOUD” podcast to discuss the results of a two-year investigation.

Also on this week’s episode, we discuss Novartis’ effort to acquire MorphoSys, and the latest news on Eli Lilly and Novo Nordisk’s blockbuster obesity drugs with Elaine Chen, the newest member of STAT’s biotech reporting team.

For more on what we cover, here’s STAT’s investigation into the Mount Sinai brain-tissue research project; here’s exclusive reporting on the MorphoSys drug at the center of the Novartis acquisition, and Adam Feuerstein’s take on where it might run off the rails; and here’s STAT’s reporting on Novo Nordisk and its weight loss drug Wegovy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Eight reasons why you should get an updated Covid vaccine

WSS

Better Therapeutics data on benefit with GLP

EPA limits use of carcinogenic gas for sterilizing medical devices

Nick Jonas talks about managing diabetes along with his career

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Peter Marks talks Operation Warp Speed for Rare Diseases

Massive project maps cells in human brain in unprecedented detail

Wikipedia

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

Novavax promises a turnaround & Lilly roils the obesity market

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

A revolution in caring for preterm infants

BioMarin wins approval for gene therapy to treat hemophilia A

Amid AI frenzy, a top HHS official's quest to create safeguards

Duchenne breakthrough therapy leaves behind pioneering families

John Green on his newest strategy for fighting tuberculosis

DIEP, the 'gold standard' of breast reconstruction, is under threat

How should state employee insurance handle Wegovy?

explore

Ebola: Gilead Sciences antiviral shows promise as new treatment

European regulators consider appeal over Amylyx ALS drug

European regulators consider appeal over Amylyx ALS drug

EPA limits use of carcinogenic gas for sterilizing medical devices

President Biden's budget: Here's what you might have missed

WuXi out of biotech trade group, U.S. and China relations to blame

entertainment

knowledge

focus

explore